Impress

Impress, branded as "Europe's Nº 1 chain of Orthodontic clinics," presents a compelling opportunity for investors seeking to tap into the transformative health care industry. Established in 2019 and headquartered in Spain, Impress has rapidly expanded its footprint, boasting over 110 clinics across Europe and the United States. The company specializes in cutting-edge clear aligner treatments that have captivated both orthodontists and patients alike.

Their commitment to customer satisfaction is evident, with more than 200,000 patients having already transformed their smiles. With over 15 years of expertise among its team, Impress delivers personalized treatment plans yielding results in as little as six months. Aiding their growth strategy, they recently acquired DR SMILE in 2024, further entrenching their leadership role in the orthodontics sector.

Their latest Venture Round on 09 June 2023, featuring investors such as Channel 4 Ventures and Redbus Ventures, underlines the investment confidence in Impress. With ambition to continue expanding, Impress offers a promising investment case.